Pyxis Oncology
PYXS
Pyxis Oncology (PYXS) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.35
- EPS estimate
- −$0.33
- EPS surprise
- −4.79%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 3, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 3, 2025 | −$0.33 | −$0.35 | −4.79% | $0.00 | SEC |
| Q2 2025 | Aug 14, 2025 | −$0.35 | −$0.30 | +14.70% | $2.8M | SEC |
| Q1 2025 | May 15, 2025 | −$0.29 | −$0.35 | −19.05% | $0.00 | SEC |
| Q4 2024 | Mar 18, 2025 | −$0.32 | −$0.62 | −93.63% | $0.00 | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.32 | −$0.35 | −9.92% | $0.00 | SEC |
| Q2 2024 | Aug 14, 2024 | −$0.34 | −$0.29 | +14.28% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$0.24 | −$0.06 | +74.85% | $16.1M | SEC |
| Q4 2023 | Mar 21, 2024 | −$0.47 | −$0.34 | +28.41% | $0.00 | SEC |
| Q3 2023 | Nov 7, 2023 | −$0.51 | −$0.56 | −10.48% | $0.00 | SEC |
| Q2 2023 | Aug 11, 2023 | −$0.65 | −$0.41 | +36.60% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.90 | −$0.54 | +39.95% | $0.00 | SEC |
| Q4 2022 | Mar 22, 2023 | −$0.93 | −$1.04 | −11.79% | $0.00 | SEC |
| Q3 2022 | Nov 1, 2022 | −$0.81 | −$0.85 | −4.49% | $0.00 | SEC |
| Q2 2022 | Aug 15, 2022 | −$0.76 | −$0.79 | −3.66% | $0.00 | SEC |
| Q1 2022 | May 13, 2022 | −$0.61 | −$0.97 | −59.09% | $0.00 | SEC |
| Q4 2021 | Mar 29, 2022 | −$0.37 | −$0.53 | −43.68% | $0.00 | SEC |
| Q3 2021 | Nov 15, 2021 | −$0.53 | −$8.96 | −1605.69% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Pyxis Oncology (PYXS) last report earnings?
Pyxis Oncology last reported on Nov 3, 2025, covering fiscal Q3 2025.
Did PYXS beat earnings estimates?
No. Pyxis Oncology reported EPS of −$0.35 for Q3 2025 against a −$0.33 estimate — a 4.79% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.